Your browser doesn't support javascript.
loading
A Global Systematic Review of Hepatitis C Elimination Efforts through Micro-Elimination.
Lazarus, Jeffrey V; Picchio, Camila A; Byrne, Christopher J; Crespo, Javier; Colombo, Massimo; Cooke, Graham S; Dore, Gregory J; Grebely, Jason; Ward, John W; Dillon, John F.
Afiliação
  • Lazarus JV; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic de Barcelona, Spain.
  • Picchio CA; Faculty of Medicine, University of Barcelona, Barcelona, Spain.
  • Byrne CJ; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic de Barcelona, Spain.
  • Crespo J; Division of Molecular and Clinical Medicine, University of Dundee School of Medicine, Ninewells Hospital, Dundee, United Kingdom.
  • Colombo M; Department of Gastroenterology and Hepatology, University Hospital Marques de Valdecilla. Research Institute Valdecilla-IDIVAL, Santander, Spain.
  • Cooke GS; General Medicine & Liver Center, San Raffaele Hospital, Milan, Italy.
  • Dore GJ; Division of Infectious Diseases, Faculty of Medicine, Imperial College London, United Kingdom.
  • Grebely J; The Kirby Institute, UNSW Sydney, Australia.
  • Ward JW; The Kirby Institute, UNSW Sydney, Australia.
  • Dillon JF; Coalition for Global Hepatitis Elimination, The Task Force for Global Health, Atlanta, United States.
Semin Liver Dis ; 42(2): 159-172, 2022 05.
Article em En | MEDLINE | ID: mdl-35189667
ABSTRACT
Microelimination targets specific subpopulations and/or geographic settings for hepatitis C virus (HCV) elimination. This review reports on global HCV microelimination literature published from 2013 to 2020. Data were extracted from publications to report a score based on the four key components defining microelimination. Sustained virologic response (SVR) and treatment initiation proportions were calculated for each manuscript and grouped means of these estimates were compared depending on microelimination score and care setting. A total of 83% of the studies were from high-income settings and mainly included people who use drugs or those incarcerated. Among manuscripts, 18 had "low" microelimination scores, 11 had "high" scores, and the differences in mean proportion who initiated treatment and achieved SVR between low and high score groups were statistically significant. Microelimination can be a useful complementary strategy for driving engagement in HCV treatment and cure. Our analysis suggests that adhering to more of the core microelimination components can improve outcomes. This study is registered with Prospero, registration identification CRD42020175211.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatite C / Hepatite C Crônica Tipo de estudo: Diagnostic_studies / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Semin Liver Dis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatite C / Hepatite C Crônica Tipo de estudo: Diagnostic_studies / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Semin Liver Dis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha